Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacific Biosciences of California Inc (NASDAQ:PACB)

2.65
Delayed Data
As of Jan 19
 -0.05 / -1.85%
Today’s Change
2.51
Today|||52-Week Range
5.74
+0.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues25.7M24.9M20.1M23.5M
 
 
 
 
 
Cost of Goods Sold13.3M13.1M10.1M13.5M
 
 
 
 
 
Depreciation And Amortization1.1M2.9M2.0M1.8M
 
 
 
 
 
 
Operating ExpensesGross Income11.4M8.9M8.0M8.2M
 
 
 
 
 
General Expenses29.2M32.2M32.4M29.8M
 
 
 
 
 
Research And Development16.3M17.0M16.9M15.8M
 
 
 
 
 
Total Operating Expenses43.6M48.2M44.5M45.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.9M-23.3M-24.4M-21.6M
 
 
 
 
 
Extraordinary Credit0.00148.0K193.0K--
 
 
 
Extraordinary Charge-138.0K0.000.00-155.0K
 
 
 
Interest Expense On Debt839.0K838.0K826.0K633.0K
 
 
 
 
 
Other Expenses-179.0K122.0K-519.0K336.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M-23.9M-25.5M-22.0M
 
 
 
 
 
Net Income-19.0M-23.9M-25.5M-22.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS92.7M93.0M97.4M115.8M
 
 
 
 
 
Shares To Calculate EPS Diluted92.7M93.0M97.4M115.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.21-$0.26-$0.26-$0.19
 
 
 
 
 
EPS Diluted-$0.21-$0.26-$0.26-$0.19